Developed based on proprietary sequential lateral flow (SLF), the new platform will enable a walk-away solution for the immunodetection step in a western blotting workflow.
SLF technology has been designed to automate the blocking, primary and secondary antibody binding and washing steps for immunodetection of proteins transferred to a nitrocellulose or PVDF membrane.
Thermo Fisher Scientific protein biology senior product manager Kevin Lowitz said: "We are thrilled to introduce the next generation iBind Flex device and consumables to address a latent need that affects a large segment of life science researchers worldwide who frequently perform western blotting."
Researchers can use the iBind Flex western device in a variety of blot formats and sample throughput and is compatible with downstream chemiluminescent, colorimetric or fluorescent detection protocols.
It can be optimized for higher sensitivity and reproducibility, allowing for a significant reduction in primary antibody required when compared to manual blot processing.
The company noted that iBind is for research use only and not for use in diagnostic procedures.
Image: Thermo Fisher Scientific’s new iBind Flex western system. Photo: courtesy of Thermo Fisher Scientific Inc.
